Samineh Sehatbakhsh, MD
Cardiovascular Disease · Ocala, FLNPI 1801281647
Payments from drug & device makers
What this record shows
This record is dominated by grants: $26,250 of the $37,799 with a category attached, or 69.4%. 14 manufacturers reported payments, led by Medtronic at 47.0% of the total. Reporting peaked in 2022 at $17,186 and has fallen 79.4% since, to $3,533 in 2025. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $293.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- Abbott$15K
- Edwards Lifesciences$2K
- Boston Scientific$1K
- Penumbra, Inc.$1K
- Teleflex LLC$269
- plus $786 from 8 others
What the payments were for
- Grants$26,25069%
- Travel & lodging$4,00511%
- Food & beverage$7,44420%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $17,774 |
| Abbott | 31 | $14,670 |
| Edwards Lifesciences | 24 | $2,146 |
| Boston Scientific | 22 | $1,104 |
| Penumbra, Inc. | 3 | $1,050 |
| Teleflex LLC | 2 | $269 |
| Astellas Pharma US Inc | 2 | $224 |
| AstraZeneca | 2 | $132 |
| Cardiovascular Systems Inc. | 1 | $119 |
| Akcea Therapeutics, Inc. | 1 | $108 |
| Novartis | 1 | $93 |
| Cardinal Health 200 LLC | 1 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $37 |
| Biosense Webster, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NAVITOR$1,945
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,502
- Indigo System$1,035
- COREVALVE EVOLUT R$982
- MitraClip$492
- WATCHMAN FLX$291
- SAPIEN 3 Ultra RESILIA$279
- RESOLUTE ONYX$275
- MANTA$269
- Omnilink Elite vascular stent system$194
- Resolute$172
- Farapulse$142
- PORTICO$133
- Diamondback Coronary$119
- FARXIGA$114
- GENERAL - THERAPIES$114
- TEGSEDI$108
- Claria MRI$102
How this compares
$37,799 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 94 | $943 |
| Rosuvastatin Calcium | 26 | $248 |
| Atorvastatin Calcium | 15 | $88 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Ocala
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
- Neel PatelMaitland$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.